Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04421963
Title Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With Olaparib (ROSY-O)
Recruitment Enrolling by invitation
Gender female
Phase Phase III
Variant Requirements No
Sponsors AstraZeneca
Indications

endometrioid ovary carcinoma

ovarian serous carcinoma

Therapies

Olaparib

Age Groups: adult | senior
Covered Countries USA | ITA | FRA | ESP | DEU | CAN | BEL


No variant requirements are available.